Last update 27 Dec 2024
Ranibizumab biosimilar (Shanghai Biomabs)
Last update 27 Dec 2024
Overview
Basic Info
Drug Type Fab fragment, Biosimilar |
Synonyms Ranibizumab biosimilar, CMAB-818, CMAB818 |
Target |
Mechanism VEGF-A inhibitors(Vascular endothelial growth factor A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Gene Sequence
Sequence Code 103170L
The sequence is quoted from: *****
Sequence Code 143622H
The sequence is quoted from: *****
Related
2
Clinical Trials associated with Ranibizumab biosimilar (Shanghai Biomabs)一项随机、双盲、平行对照，比较CMAB818 注射液与诺适得®在湿性年龄相关性黄斑变性患者的安全性、免疫原性、药代动力学、药效学和初步疗效的I 期研究。
[Translation] A randomized, double-blind, parallel-controlled Phase I study comparing the safety, immunogenicity, pharmacokinetics, pharmacodynamics and preliminary efficacy of CMAB818 injection with Lusitanicotinamide® in patients with wet age-related macular degeneration.
A Randomized, Double-blind, Two-group Parallel, Positive-controlled Clinical Phase I Trial Comparing the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of CMAB818 and Lucentis® in Patients With Wet Age-related Macular Degeneration.
100 Clinical Results associated with Ranibizumab biosimilar (Shanghai Biomabs)
Login to view more data
100 Translational Medicine associated with Ranibizumab biosimilar (Shanghai Biomabs)
Login to view more data
100 Patents (Medical) associated with Ranibizumab biosimilar (Shanghai Biomabs)
Login to view more data
100 Deals associated with Ranibizumab biosimilar (Shanghai Biomabs)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Wet age-related macular degeneration | Phase 1 | CN | 03 Jun 2021 | |
| Wet Macular Degeneration | Phase 1 | CN | 03 Jun 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free